Fig. 1
From: Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy
Brain MRI obtained at onset of neurological symptoms. T1-weighted contrast-enhanced axial image shows leptomeningeal enhancement involving the left occipital and parietal lobes (arrows)